As probiotics move into mainstream healthcare, typical first-line drug treatments are being questioned. But old habits die hard in the juggernaut that is the medical-pharmaceutical complex. One particular disorder appears ripe for disruption. The role of gut microbiota in irritable bowel syndrome (IBS) is amassing evidence-based research attesting to its importance. Irritable bowel syndrome (IBS) […]